DK0750616T3 - Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser - Google Patents
Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelserInfo
- Publication number
- DK0750616T3 DK0750616T3 DK95912143T DK95912143T DK0750616T3 DK 0750616 T3 DK0750616 T3 DK 0750616T3 DK 95912143 T DK95912143 T DK 95912143T DK 95912143 T DK95912143 T DK 95912143T DK 0750616 T3 DK0750616 T3 DK 0750616T3
- Authority
- DK
- Denmark
- Prior art keywords
- tetrahydro
- benzazapine
- compounds
- acid addition
- addition salts
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- DIKLCFJDIZFAOM-INIZCTEOSA-N (5s)-5-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol Chemical class C1N(C)CCC2=CC(Cl)=C(O)C=C2[C@H]1C1=CC(Br)=CC2=C1OCC2 DIKLCFJDIZFAOM-INIZCTEOSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK31194 | 1994-03-16 | ||
| PCT/DK1995/000106 WO1995025102A1 (fr) | 1994-03-16 | 1995-03-08 | Sels d'addition d'acide de composes de 2,3,4,5-tetrahydro-1h-3-benzazepine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0750616T3 true DK0750616T3 (da) | 2001-07-23 |
Family
ID=8092128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95912143T DK0750616T3 (da) | 1994-03-16 | 1995-03-08 | Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5658899A (fr) |
| EP (1) | EP0750616B1 (fr) |
| JP (1) | JPH09510222A (fr) |
| AT (1) | ATE201680T1 (fr) |
| AU (1) | AU1945495A (fr) |
| DE (1) | DE69521122T2 (fr) |
| DK (1) | DK0750616T3 (fr) |
| ES (1) | ES2158094T3 (fr) |
| IL (1) | IL112999A0 (fr) |
| WO (1) | WO1995025102A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410527B1 (en) * | 1998-03-02 | 2002-06-25 | Schering Corporation | Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
| DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| DE10000577A1 (de) * | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| AU2002219236B2 (en) | 2001-01-12 | 2006-02-09 | Biogen International Gmbh | Fumaric acid amides |
| UA79248C2 (en) * | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| HRP20050110A2 (en) * | 2002-08-05 | 2006-02-28 | Sandoz Ag | Novel salt and polymorphs of desloratadine hemifumarate |
| ATE380027T1 (de) | 2003-09-09 | 2007-12-15 | Fumapharm Ag | Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma |
| PT2137537E (pt) | 2007-02-08 | 2013-08-22 | Biogen Idec Inc | Composições e respectivas utilizações para o tratamento da esclerose múltipla |
| KR20180128987A (ko) | 2011-09-16 | 2018-12-04 | 퍼시몬 테크놀로지스 코포레이션 | 기판 이동 장치 |
| JP6181754B2 (ja) | 2012-07-12 | 2017-08-16 | サイエドン ファーマシューティカルズ， インコーポレイテッド | トゥレット症候群治療のための縮合ベンゾアゼピン |
| SMT202000398T1 (it) | 2013-10-18 | 2020-09-10 | Emalex Biosciences Inc | Benzazepine fuse per il trattamento della balbuzie |
| WO2015112538A1 (fr) | 2014-01-21 | 2015-07-30 | Persimmon Technologies, Corp. | Plate-forme sous vide de transport de substrats |
| WO2025194153A1 (fr) | 2024-03-15 | 2025-09-18 | Emalex Biosciences, Inc. | Formes posologiques pharmaceutiques et méthodes d'utilisation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470850A (en) * | 1992-02-24 | 1995-11-28 | Novo Nordisk A/S | 2,3,4,5-tetrahydro-1H-3-benzazepines |
| DK23392D0 (da) * | 1992-02-24 | 1992-02-24 | Novo Nordisk As | Heterocykliske forbindelser, deres anvendelse og fremstilling |
-
1995
- 1995-03-08 JP JP7523785A patent/JPH09510222A/ja active Pending
- 1995-03-08 AT AT95912143T patent/ATE201680T1/de not_active IP Right Cessation
- 1995-03-08 WO PCT/DK1995/000106 patent/WO1995025102A1/fr not_active Ceased
- 1995-03-08 DK DK95912143T patent/DK0750616T3/da active
- 1995-03-08 AU AU19454/95A patent/AU1945495A/en not_active Abandoned
- 1995-03-08 ES ES95912143T patent/ES2158094T3/es not_active Expired - Lifetime
- 1995-03-08 DE DE69521122T patent/DE69521122T2/de not_active Expired - Lifetime
- 1995-03-08 EP EP95912143A patent/EP0750616B1/fr not_active Expired - Lifetime
- 1995-03-14 US US08/404,394 patent/US5658899A/en not_active Expired - Lifetime
- 1995-03-15 IL IL11299995A patent/IL112999A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1945495A (en) | 1995-10-03 |
| EP0750616B1 (fr) | 2001-05-30 |
| ATE201680T1 (de) | 2001-06-15 |
| US5658899A (en) | 1997-08-19 |
| IL112999A0 (en) | 1995-06-29 |
| JPH09510222A (ja) | 1997-10-14 |
| DE69521122D1 (de) | 2001-07-05 |
| DE69521122T2 (de) | 2002-03-07 |
| EP0750616A1 (fr) | 1997-01-02 |
| WO1995025102A1 (fr) | 1995-09-21 |
| ES2158094T3 (es) | 2001-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITFI910071U1 (it) | Piastra per osso per la porzione distale dell'omero. | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| SE9504661D0 (sv) | New compounds | |
| EE03741B1 (et) | N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine | |
| CY1116988T1 (el) | Βητα-l-2'-δεοξυ-νουκλεοζιτες για την θεραπεια ηπατιτιδας β | |
| ES2051641A1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
| NO963239L (no) | Klorpyrimid-mellomprodukter | |
| DE69200675D1 (de) | Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen. | |
| TR199901305T2 (xx) | Calpain-�nleyicileri olarak ketonbenzamidler | |
| TR199700844T1 (xx) | Pirazolil-Benzoil T�revleri. | |
| DE69100848D1 (de) | Hautpflegezusammensetzungen. | |
| DE69007080D1 (de) | Orale Hygienezusammensetzung. | |
| DK0998287T3 (da) | Anvendelse af levobupivacain | |
| DK0750616T3 (da) | Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser | |
| ATE288900T1 (de) | Substituierte benzoylcyclohexandione | |
| BR9509975A (pt) | Formulação farmacêutica | |
| IT8919074A0 (it) | Composizione per l'igiene orale. | |
| ITMI913465A1 (it) | Procedimento per la depurazione dell'1, 1, 1-trifluoro-2-fluoroetano | |
| IT9047924A0 (it) | Composizione per l'igiene orale. | |
| DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| ATE125541T1 (de) | Reine kristalline form von rifapentin. | |
| SE9504662D0 (sv) | New compounds | |
| DE69936052D1 (de) | N1 modifizierte glycopeptide | |
| TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
| YU82693A (sh) | Farmaceutske formulacije disulfonil metana i novi disulfonil metani |